Hans Edgar Bishop is of Lyell Immunopharma, Inc.. Currently has a direct ownership of 4.69 Million shares of LYEL, which is worth approximately $2.86 Million. The most recent transaction as insider was on Sep 08, 2022, when has been sold 145,380 shares (Common Stock) at a price of $0.1 per share, resulting in proceeds of $14,538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.69M
0% 3M change
0% 12M change
Total Value Held $2.86 Million

Hans Edgar Bishop Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 08 2022
BUY
Exercise of conversion of derivative security
$14,538 $0.1 p/Share
145,380 Added 3.01%
4,685,614 Common Stock
Feb 23 2022
BUY
Exercise of conversion of derivative security
$99,343 $0.1 p/Share
993,428 Added 17.95%
4,540,234 Common Stock
Jun 21 2021
BUY
Conversion of derivative security
-
546,806 Added 13.36%
3,546,806 Common Stock

Also insider at

SANA
Sana Biotechnology, Inc. Healthcare
A
AGILENT TECHNOLOGIES, INC. Healthcare
HEB

Hans Edgar Bishop

Seattle, WA

Track Institutional and Insider Activities on LYEL

Follow Lyell Immunopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LYEL shares.

Notify only if

Insider Trading

Get notified when an Lyell Immunopharma, Inc. insider buys or sells LYEL shares.

Notify only if

News

Receive news related to Lyell Immunopharma, Inc.

Track Activities on LYEL